Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 20,000 shares at $80.06 ($1.6M) on 2024-04-03, disclosed to the SEC on 2024-04-05.
Scheduled sale ($1.6M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.06 | 5,053 | $405K | 25.2% |
| 2 | $80.06 | 5,053 | $405K | 25.2% |
| 3 | $80.36 | 4,947 | $398K | 24.8% |
| 4 | $80.36 | 4,947 | $398K | 24.8% |
| Total | $80.21 avg | 20,000 | $1.6M | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |